Order Article Reprints

Seetharaman A, Christopher V, Dhandapani H, Jayakumar H, Dhanushkodi M, Bhaskaran N, Rajaraman S, Ranganathan R, Sunder Singh S, Vijayakumar V, et al. Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources. Vaccines. 2024; 12(2):112. https://doi.org/10.3390/vaccines12020112

Seetharaman, Abirami, Vasanth Christopher, Hemavathi Dhandapani, Hascitha Jayakumar, Manikandan Dhanushkodi, Narmadha Bhaskaran, Swaminathan Rajaraman, Rama Ranganathan, Shirley Sunder Singh, Varalakshmi Vijayakumar, and et al. 2024. "Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources" Vaccines 12, no. 2: 112. https://doi.org/10.3390/vaccines12020112

Seetharaman, A., Christopher, V., Dhandapani, H., Jayakumar, H., Dhanushkodi, M., Bhaskaran, N., Rajaraman, S., Ranganathan, R., Sunder Singh, S., Vijayakumar, V., Rajamanickam, A., Suri, A., Jagadish, N., Rajkumar, T., & Ramanathan, P. (2024). Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources. Vaccines, 12(2), 112. https://doi.org/10.3390/vaccines12020112